Z-1107-2019 Class III Terminated

Recalled by Randox Laboratories Ltd. — Crumlin (North), N/A

FDA device recall Z-1107-2019 was initiated by Randox Laboratories Ltd. on Feb 7, 2019 and is designated Class III. Reason for recall: The target value for uptake is incorrect on the value sheet for an analyzer. The target value for this analyzer is listed as 43.8%U and should be 39.4%U. The recall status is terminated (terminated Jun 8, 2020). Affected quantity: 4.

Recall details

Product Type
Devices
Report Date
Apr 17, 2019
Initiation Date
Feb 7, 2019
Termination Date
Jun 8, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4

Product description

Liquid Immunoassay Premium Controls, Model Number LIA3105 Product Usage: This product is intended for in vitro diagnostic use, as assayed quality control material to monitor the accuracy and reproducibility of analytes listed in the package insert

Reason for recall

The target value for uptake is incorrect on the value sheet for an analyzer. The target value for this analyzer is listed as 43.8%U and should be 39.4%U.

Distribution pattern

The products were distributed to the following US states: WV and Puerto Rico.

Code information

Lot codes: 1723EC

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1107-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1107-2019. Report a data issue: hello@regdatalab.com.